High Frequency of Aneuploidy Defines Ulcerative Colitis-Associated Carcinomas

Standard

High Frequency of Aneuploidy Defines Ulcerative Colitis-Associated Carcinomas : A Prognostic Comparison to Sporadic Colorectal Carcinomas. / Gerling, Marco; Meyer, Karl F; Fuchs, Katrin; Igl, Bernd W; Fritzsche, Britta; Ziegler, Andreas; Bader, F; Kujath, Peter; Schimmelpenning, Hendrik; Bruch, Hans-Peter; Roblick, Uwe J; Habermann, Jens K.

In: ANN SURG, Vol. 252, No. 1, 07.2010, p. 74-83.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearch

Harvard

Gerling, M, Meyer, KF, Fuchs, K, Igl, BW, Fritzsche, B, Ziegler, A, Bader, F, Kujath, P, Schimmelpenning, H, Bruch, H-P, Roblick, UJ & Habermann, JK 2010, 'High Frequency of Aneuploidy Defines Ulcerative Colitis-Associated Carcinomas: A Prognostic Comparison to Sporadic Colorectal Carcinomas', ANN SURG, vol. 252, no. 1, pp. 74-83. https://doi.org/10.1097/SLA.0b013e3181deb664

APA

Gerling, M., Meyer, K. F., Fuchs, K., Igl, B. W., Fritzsche, B., Ziegler, A., Bader, F., Kujath, P., Schimmelpenning, H., Bruch, H-P., Roblick, U. J., & Habermann, J. K. (2010). High Frequency of Aneuploidy Defines Ulcerative Colitis-Associated Carcinomas: A Prognostic Comparison to Sporadic Colorectal Carcinomas. ANN SURG, 252(1), 74-83. https://doi.org/10.1097/SLA.0b013e3181deb664

Vancouver

Bibtex

@article{2d3baf167c584d5ba2881f8100f92824,
title = "High Frequency of Aneuploidy Defines Ulcerative Colitis-Associated Carcinomas: A Prognostic Comparison to Sporadic Colorectal Carcinomas",
abstract = "OBJECTIVE: Aneuploidy is an independent risk factor for forthcoming carcinogenesis in ulcerative colitis (UC). An inferior prognosis of patients with ulcerative colitis-associated colorectal cancer (UCC) compared with those with sporadic colorectal cancer (SCC) has been reported, but remains controversial. This prompted us to investigate if aneuploidy can be observed in UCCs as frequently as in their sporadic counterpart and if aneuploidy per se might be a driving feature of poor prognosis in UCC.BACKGROUND DATA: We obtained clinical follow-up for 257 SCC patients (average observation time 57 months) and 31 UCC patients (51 months). Touch preparation slides or tissue sections were prepared of all 288 carcinomas for ploidy analysis.METHODS: Ploidy status was assessed for 260 SCCs and 31 UCCs by image cytometry and correlated to clinical features. Survival data were analyzed using Kaplan-Meier estimates.RESULTS: Aneuploidy was detected in 74.6% of SCCs and in all 31 UCCs. Logistic regression analysis yielded age (odds ratio [OR], 1.05; 95% CI, 1.02-1.09; P = 0.003) and aneuploidy (OR, 4.07; 95% CI, 1.46-11.36; P = 0.007) as independent prognostic factors for R0-resected patients devoid of metastases. Diploid SCCs had a more favorable 5-year survival (88.2%) than aneuploid SCCs (69.0%) and UCCs (73.1%) (P = 0.074).CONCLUSIONS: UC-associated carcinomas presented aneuploidy at significantly higher frequency than sporadic colorectal carcinomas (P < 0.0006). UCCs and aneuploid SCCs share a similar prognosis inferior to that of diploid SCCs. Aneuploidy proved to be the strongest independent prognostic marker for R0-resected colorectal cancer patients overall.",
keywords = "Aged, Aneuploidy, Colitis, Ulcerative, Colorectal Neoplasms, DNA, Neoplasm, Female, Humans, Male, Middle Aged, Prognosis, Comparative Study, Journal Article, Research Support, Non-U.S. Gov't",
author = "Marco Gerling and Meyer, {Karl F} and Katrin Fuchs and Igl, {Bernd W} and Britta Fritzsche and Andreas Ziegler and F Bader and Peter Kujath and Hendrik Schimmelpenning and Hans-Peter Bruch and Roblick, {Uwe J} and Habermann, {Jens K}",
year = "2010",
month = jul,
doi = "10.1097/SLA.0b013e3181deb664",
language = "English",
volume = "252",
pages = "74--83",
journal = "ANN SURG",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

RIS

TY - JOUR

T1 - High Frequency of Aneuploidy Defines Ulcerative Colitis-Associated Carcinomas

T2 - A Prognostic Comparison to Sporadic Colorectal Carcinomas

AU - Gerling, Marco

AU - Meyer, Karl F

AU - Fuchs, Katrin

AU - Igl, Bernd W

AU - Fritzsche, Britta

AU - Ziegler, Andreas

AU - Bader, F

AU - Kujath, Peter

AU - Schimmelpenning, Hendrik

AU - Bruch, Hans-Peter

AU - Roblick, Uwe J

AU - Habermann, Jens K

PY - 2010/7

Y1 - 2010/7

N2 - OBJECTIVE: Aneuploidy is an independent risk factor for forthcoming carcinogenesis in ulcerative colitis (UC). An inferior prognosis of patients with ulcerative colitis-associated colorectal cancer (UCC) compared with those with sporadic colorectal cancer (SCC) has been reported, but remains controversial. This prompted us to investigate if aneuploidy can be observed in UCCs as frequently as in their sporadic counterpart and if aneuploidy per se might be a driving feature of poor prognosis in UCC.BACKGROUND DATA: We obtained clinical follow-up for 257 SCC patients (average observation time 57 months) and 31 UCC patients (51 months). Touch preparation slides or tissue sections were prepared of all 288 carcinomas for ploidy analysis.METHODS: Ploidy status was assessed for 260 SCCs and 31 UCCs by image cytometry and correlated to clinical features. Survival data were analyzed using Kaplan-Meier estimates.RESULTS: Aneuploidy was detected in 74.6% of SCCs and in all 31 UCCs. Logistic regression analysis yielded age (odds ratio [OR], 1.05; 95% CI, 1.02-1.09; P = 0.003) and aneuploidy (OR, 4.07; 95% CI, 1.46-11.36; P = 0.007) as independent prognostic factors for R0-resected patients devoid of metastases. Diploid SCCs had a more favorable 5-year survival (88.2%) than aneuploid SCCs (69.0%) and UCCs (73.1%) (P = 0.074).CONCLUSIONS: UC-associated carcinomas presented aneuploidy at significantly higher frequency than sporadic colorectal carcinomas (P < 0.0006). UCCs and aneuploid SCCs share a similar prognosis inferior to that of diploid SCCs. Aneuploidy proved to be the strongest independent prognostic marker for R0-resected colorectal cancer patients overall.

AB - OBJECTIVE: Aneuploidy is an independent risk factor for forthcoming carcinogenesis in ulcerative colitis (UC). An inferior prognosis of patients with ulcerative colitis-associated colorectal cancer (UCC) compared with those with sporadic colorectal cancer (SCC) has been reported, but remains controversial. This prompted us to investigate if aneuploidy can be observed in UCCs as frequently as in their sporadic counterpart and if aneuploidy per se might be a driving feature of poor prognosis in UCC.BACKGROUND DATA: We obtained clinical follow-up for 257 SCC patients (average observation time 57 months) and 31 UCC patients (51 months). Touch preparation slides or tissue sections were prepared of all 288 carcinomas for ploidy analysis.METHODS: Ploidy status was assessed for 260 SCCs and 31 UCCs by image cytometry and correlated to clinical features. Survival data were analyzed using Kaplan-Meier estimates.RESULTS: Aneuploidy was detected in 74.6% of SCCs and in all 31 UCCs. Logistic regression analysis yielded age (odds ratio [OR], 1.05; 95% CI, 1.02-1.09; P = 0.003) and aneuploidy (OR, 4.07; 95% CI, 1.46-11.36; P = 0.007) as independent prognostic factors for R0-resected patients devoid of metastases. Diploid SCCs had a more favorable 5-year survival (88.2%) than aneuploid SCCs (69.0%) and UCCs (73.1%) (P = 0.074).CONCLUSIONS: UC-associated carcinomas presented aneuploidy at significantly higher frequency than sporadic colorectal carcinomas (P < 0.0006). UCCs and aneuploid SCCs share a similar prognosis inferior to that of diploid SCCs. Aneuploidy proved to be the strongest independent prognostic marker for R0-resected colorectal cancer patients overall.

KW - Aged

KW - Aneuploidy

KW - Colitis, Ulcerative

KW - Colorectal Neoplasms

KW - DNA, Neoplasm

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Prognosis

KW - Comparative Study

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

U2 - 10.1097/SLA.0b013e3181deb664

DO - 10.1097/SLA.0b013e3181deb664

M3 - SCORING: Journal article

C2 - 20531006

VL - 252

SP - 74

EP - 83

JO - ANN SURG

JF - ANN SURG

SN - 0003-4932

IS - 1

ER -